Literature DB >> 8423070

Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model.

K H Mills1, A Barnard, J Watkins, K Redhead.   

Abstract

A murine respiratory infection model was used to study the mechanism of protective immunity to Bordetella pertussis. We found that nude mice, which are deficient in T cells, developed a persistent infection and failed to clear the bacteria after aerosol inoculation. In contrast, normal adult nonimmune mice cleared a respiratory infection approximately 35 days after challenge. Before bacterial clearance, antipertussis antibody levels in serum were low or undetectable, whereas consistent antigen-specific T-cell responses were demonstrated throughout the course of infection. The in vitro responses detected in immune spleen cells were mediated by a population of CD4+ major histocompatibility complex class II-restricted Th1-like cells that secreted interleukin-2 and gamma interferon but not interleukin-4. Adoptive transfer of immune spleen cells into nude or sublethally irradiated immunosuppressed mice before challenge resulted in bacterial clearance within 14 to 21 days. In contrast, injection of serum from convalescent mice before challenge only marginally reduced the bacterial load early in the course of infection. Furthermore, transfer of enriched T cells or purified CD4+ T cells but not CD8+ T cells from immune mice conferred a high level of protection. Recipients of CD4+ T cells cleared the bacteria from the lungs within 20 days of challenge, at which time B. pertussis-specific antibodies in the serum were undetectable. Although we do not rule out a contribution of mucosal immunoglobulin A, our findings suggest that cellular responses mediated by CD4+ Th1 cells play an important role in protective immunity to B. pertussis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423070      PMCID: PMC302743          DOI: 10.1128/iai.61.2.399-410.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Development of an acellular pertussis vaccine and its administration as a booster in healthy adults.

Authors:  O Ruuskanen; A Noel; A Putto-Laurila; J Pêtre; C Capiau; A Delem; D Vandevoorde; E Simoen; D E Teuwen; H Bogaerts
Journal:  Vaccine       Date:  1991-02       Impact factor: 3.641

2.  CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.

Authors:  W R Weiss; M Sedegah; R L Beaudoin; L H Miller; M F Good
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  The recurrence of whooping cough: possible implications for assessment of vaccine efficacy.

Authors:  P E Fine; J A Clarkson
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

4.  Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.

Authors:  Y Sato; K Izumiya; H Sato; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

5.  Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis.

Authors:  I G Charles; J L Li; M Roberts; K Beesley; M Romanos; D J Pickard; M Francis; D Campbell; G Dougan; M J Brennan
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

6.  Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels.

Authors:  L A Ashworth; R B Fitzgeorge; L I Irons; C P Morgan; A Robinson
Journal:  J Hyg (Lond)       Date:  1982-06

7.  Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells.

Authors:  E I Tuomanen; L A Zapiain; P Galvan; E L Hewlett
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

8.  The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effects.

Authors:  L M Kumaratilake; A Ferrante; C Rzepczyk
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

9.  Effect of vaccination on severity and dissemination of whooping cough.

Authors:  P R Grob; M J Crowder; J F Robbins
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

10.  Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization.

Authors:  K Saukkonen; C Cabellos; M Burroughs; S Prasad; E Tuomanen
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  125 in total

1.  Phagocytosed Bordetella pertussis fails to survive in human neutrophils.

Authors:  D H Lenz; C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.

Authors:  C L Weingart; W A Keitel; K M Edwards; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection.

Authors:  A George-Chandy; N Mielcarek; I Nordström; J Holmgren; K Eriksson
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.

Authors:  E J Ryan; L Nilsson; N Kjellman; L Gothefors; K H Mills
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

5.  Maternal immunity provides protection against pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Inhibition of murine allergic airway disease by Bordetella pertussis.

Authors:  Young-Suk Kim; Keun-Sang Kwon; Dae-Ki Kim; Il-Whan Choi; Hern-Ku Lee
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

7.  Immunoglobulin A-mediated protection against Bordetella pertussis infection.

Authors:  S M Hellwig; A B van Spriel; J F Schellekens; F R Mooi; J G van de Winkel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Circulating fibronectin and fibronectin receptor in children with pertussis.

Authors:  D Torre; M Giola; C Zeroli; R Martegani; G Bonetta; G Ferrario
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

9.  Protecting infants from pertussis.

Authors:  Meghan Gilley; Ran D Goldman
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

10.  Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.

Authors:  Darren P Ennis; Joseph P Cassidy; Bernard P Mahon
Journal:  Clin Diagn Lab Immunol       Date:  2005-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.